---
id: "entity-aws-ddw"
type: "entity"
entityType: "product"
canonicalName: "AWS Drug Discovery Workbench"
aliases: ["AWS DDW"]
source_timestamps: ["§ 3. Use strategic partnerships to unlock the value of AI in drug discovery and development.", "¶14"]
tags: ["software", "ai-tools"]
related: ["concept-in-house-accelerators"]
sources: ["tail2"]
sourceVaultSlug: "hbr-seg-tail2"
originDay: 2
articleStem: "hbr-tail-131-medical-drug-discovery"
sourceUrl: "https://hbr.org/2026/04/u-s-medical-centers-need-a-new-model-for-drug-discovery-and-development"
sourceTitle: "U.S. Medical Centers Need a New Model for Drug Discovery and Development"
---
# AWS Drug Discovery Workbench

A **cloud-based platform** that helps researchers quickly **screen large numbers of potential drug compounds** and run **thousands of drug-binding simulations**. It appears as a strategic-partnership tool under Pillar 3 of the [[framework-amc-innovation-acceleration]].

**Enrichment caveat:** canonical context is AWS's healthcare / life-sciences cloud tooling, though the **specific product naming should be verified** against AWS documentation.